Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020).

Authors : Huang, Liling¹ (AUTHOR); Jiang, Shiyu¹ (AUTHOR); Shi, Yuankai¹ (AUTHOR)

Source: Journal of Hematology & Oncology. 10/27/2020, Vol. 13 Issue 1, p1-23. 23p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial.

Authors : Subbiah, Vivek^1,2 (AUTHOR) ; Dumbrava, Ecaterina Ileana¹ (AUTHOR); Jiang, Yunfang¹ (AUTHOR)

Source: Experimental Hematology & Oncology. 4/20/2020, Vol. 9 Issue 1, p1-8. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Graft-versus-cancereffect and innovative approaches in the treatment of refractory solid tumors.

Authors : ŞAHİN, Uğur¹; DEMİRER, Taner²

Source: Turkish Journal of Medical Sciences. 2020 Special Issue, Vol. 50, p1697-1706. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparison of deconvoluted plasma DSC curves on patients with solid tumors.

Authors : Lőrinczy, Dénes¹ (AUTHOR); Ferencz, Andrea² (AUTHOR)

Source: Journal of Thermal Analysis & Calorimetry. Nov2020, Vol. 142 Issue 3, p1243-1248. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.

Authors : Nogova, Lucia¹ (AUTHOR) ; Mattonet, Christian^1,2 (AUTHOR); Scheffler, Matthias¹ (AUTHOR)

Source: Cancer Medicine. Jul2020, Vol. 9 Issue 14, p4991-5007. 17p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors.

Authors : Zhang, Da^1,2 (AUTHOR); Zheng, Youshi² (AUTHOR); Lin, Ziguo² (AUTHOR)

Source: Angewandte Chemie. 7/13/2020, Vol. 132 Issue 29, p12120-12126. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors.

Authors : Zhang, Da^1,2 (AUTHOR); Zheng, Youshi² (AUTHOR); Lin, Ziguo² (AUTHOR)

Source: Angewandte Chemie International Edition. 7/13/2020, Vol. 59 Issue 29, p12022-12028. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization.

Authors : Jae Seung Lee^1,2; Hong Jun Choi^1,2; Beom Kyung Kim^1,2,3

Source: Gut & Liver. Nov2020, Vol. 14 Issue 6, p765-774. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors.

Authors : Patel, Chirag¹ (AUTHOR) ; Goel, Sanjay² (AUTHOR); Patel, Manish R.³ (AUTHOR)

Source: Clinical Pharmacology in Drug Development. Oct2020, Vol. 9 Issue 7, p876-888. 13p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors.

Authors : Luo, Hong¹ (AUTHOR); Zhang, Tao¹ (AUTHOR); Cheng, Peng¹ (AUTHOR)

Source: Oncology Letters. Sep2020, Vol. 20 Issue 3, p2525-2536. 12p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020).

Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial.

Graft-versus-cancereffect and innovative approaches in the treatment of refractory solid tumors.

Comparison of deconvoluted plasma DSC curves on patients with solid tumors.

Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.

Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors.

Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors.

The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization.

Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors.

Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors.

اتصل بنا

اتبع